Clinical Trial Update: Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating post-procedural pain associated with 5 versus 20 intravesical injections of onabotulinumtoxin A for overactive bladder-related…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Onabotulinumtoxin A (botulinum toxin type A)

Snippet

Sponsor: University of South Florida | Conditions: Urinary Bladder, Overactive, Incontinence, Urge | Phase 4 | Status: RECRUITING